Trademark: 98054545
Word
ACEPODIA
Status
Pending
Status Code
688
Status Date
Tuesday, June 11, 2024
Serial Number
98054545
Mark Type
4
Filing Date
Thursday, June 22, 2023
Published for Opposition
Tuesday, April 16, 2024

Trademark Owner History
Acepodia Biotechnologies Ltd. - Owner At Publication

Classifications
42 Design and testing for new cell products namely, natural killer cell, gamma delta T cell, stem cell, and other cell products; Platform as a service (PAAS) featuring computer software platforms for developing cell products to improve ability to target tumor cells or other abnormal cells; Platform as a service (PAAS) featuring computer software platforms for use with cell therapy to manufacture tumor targeted or abnormal cell targeted cell products for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease, autoimmune disease, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, immune disease or disorder, and other diseases or disorders; Providing medical and scientific research information in the field of cells and cell-derived preparations; Providing a web site featuring technology that enables users to present products in the fields of cell therapy and regenerative medicine services to others for comment and gather feedback from those others about those products

Trademark Events
Jun 26, 2023
New Application Entered
Jul 25, 2023
New Application Office Supplied Data Entered
Mar 5, 2024
Assigned To Examiner
Mar 8, 2024
Examiners Amendment -Written
Mar 8, 2024
Examiners Amendment E-Mailed
Mar 8, 2024
Notification Of Examiners Amendment E-Mailed
Mar 8, 2024
Examiner's Amendment Entered
Mar 8, 2024
Approved For Pub - Principal Register
Mar 27, 2024
Notification Of Notice Of Publication E-Mailed
Apr 16, 2024
Published For Opposition
Apr 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 11, 2024
Noa E-Mailed - Sou Required From Applicant

Trademark Alertz updated from USPTO on 2030-01-24